- South Korea
- /
- Medical Equipment
- /
- KOSDAQ:A099190
i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings
Shareholders appeared unconcerned with i-SENS, Inc.'s (KOSDAQ:099190) lackluster earnings report last week. We think that the softer headline numbers might be getting counterbalanced by some positive underlying factors.
View our latest analysis for i-SENS
The Impact Of Unusual Items On Profit
To properly understand i-SENS' profit results, we need to consider the ₩2.3b expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect i-SENS to produce a higher profit next year, all else being equal.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On i-SENS' Profit Performance
Because unusual items detracted from i-SENS' earnings over the last year, you could argue that we can expect an improved result in the current quarter. Based on this observation, we consider it likely that i-SENS' statutory profit actually understates its earnings potential! On the other hand, its EPS actually shrunk in the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. In terms of investment risks, we've identified 2 warning signs with i-SENS, and understanding these should be part of your investment process.
Today we've zoomed in on a single data point to better understand the nature of i-SENS' profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
Valuation is complex, but we're here to simplify it.
Discover if i-SENS might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSDAQ:A099190
i-SENS
Engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally.
Reasonable growth potential with mediocre balance sheet.